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SUMMARY 
Background: The leaves of Ziziphus mucronata are 
used locally as food and a health drink; the leaf paste 
can also be used in the treatment of boils. The root of 
the plant is usually used in the treatment of a wide 
range of pains. 
Objective: The study was carried out to evaluate the 
hepatoprotective potential of the methanol leaf extract 
of Ziziphus mucronata (ZMLM). 
Method: The extract was prepared by soaking in 70% 
methanol/water and rotary evaporation. The phenol 
content of extract was then estimated. Twenty five 
adult male Sprague dawley rats (aged 21 weeks) were 
divided into five groups of five rats each and treated as 
follows; normal control (NC) received distilled water. 
Dimethoate control (DC) (received 6 mg/kg.bw.day-1 
dimethoate dissolved in distilled water). Experimental 
Groups (E1) received dimethoate (6mg/kg.bw) + 
ZMLM (100 mg/kg.bw-1); (E2) received dimethoate (6 
mg/kg.bw) + ZMLM (200 mg/kg.bw-1) and (E3) 
received dimethoate (6 mg/kg.bw) + ZMLM (300 
mg/kg.bw-1). In both the cases a normal control and 
dimethoate control were kept to compare the results. 
After 90 days, blood was collected and rats were sacri-
ficed to collect the liver tissue for biochemical assays 
and histological estimations. 
Results: The results of E1 did not show much change 
from the normal control group but was significantly 
different from the dimethoate control group (P≤ 0.05). 
The preventive effect which was tested in E2 and E3 
proved that the extract could almost retain the normal 
condition in 90 days time. Histological observations 
also agreed with the results obtained in biochemical 
parameters. 
Conclusions: Ziziphus mucronata methanol leaf 
extract possesses a preventive effect against dimethoate 
induced oxidative stress as observed in male albino 
Sprague Dawley rats. 
 
Keywords: Leaf methanol extract, hepatoprotective, 
Ziziphus mucronata, oxidative stress, phenol content 
INTRODUCTION 
Pesticides are very effective in pest control and are 
sometimes used indiscriminately in large amounts that 
lead to environmental pollution. Residues of 
organochlorides and organophosphates have been 
detected in the soil, water, reservoirs, vegetables, 
grains and other food products.1 Organophosphates 
have been found to inhibit acetylcholinesterase (AchE) 
and subsequent activation of cholinergic receptors.2 
Oxidative stress caused by lipid peroxidation induced 
by dimethoate has also been found to be one of the 
molecular mechanisms involved in organophosphate 
toxicity.3,4  
 
Biotransformation of dimethoate in the cytochrome P-
450 results in the production of an oxygen analogue 
(omethoate). Omethoate is ten times more toxic 
compared to dimethoate.5 Oxidative stress is associated 
with many ailments like atherosclerosis, arthritis and 
liver diseases.4 In Africa medicinal plants are 
traditionally and carefully selected alternatives to curb 
against various ailments. Among the promising 
medicinal plants Ziziphus mucronata (ZM) in the 
family Ramnaceae is a very common tree in Botswana 
with a rich historical and religious background.  
 
The prominent usage of the plant has been observed 
among the bushman of the Okavango river bank in 
Botswana, Kavango and Zulu tribes in southern Africa 
(Koeven, 2001).6  The roots bark, and leaves of this 
plant are used in the treatment of a wide range of 
ailments, these include arthritis, chest pains, arthritis, 
boils, liver diseases and gastrointestinal problems.6 
Since dimethoate has also been reported to induce 
oxidative stress and this tree in Botswana has already 
been in use to treat the diseases caused by oxidative 
stress. Therefore, we are proposing that this tree might 
be useful in preventing and protecting the population 
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Dimethoate is locally sold in shops) throughout 
Botswana and easily available for household usage and 
for the local farmers. The study was aimed to establish 
the antioxidant and hepato-protective properties of the 
methanol extract of the leaf in albino rats. 
 
MATERIALS AND METHODS 
Chemicals 
Dimethoate emulsifiable concentrate was purchased 
from Agrivet PTY (LTD) Botswana and other 
chemicals were of analytical grade and were bought 
from Sigma-Aldrich (St. Louis, USA). The kits were 
purchased from Aggape diagnostics, Agappe Hills, 
Dist. Enakulam, and Kerala-683 562 India. 
 
Experimental Animals 
Male Sprague Dawley  albino rats aged 20-21 weeks 
were  kept in galvanized cages under controlled 
conditions of temperature at 25oc and a normal 
photoperiod (12-h dark:12-h light). The animals were 
fed commercial food pellets (protein 18%, fat 6%, fiber 
6%, carbohydrates 56%, calcium 0.6% moisture 10%) 
and water ad libitum. All procedures with animals were 
performed in accordance with University of Botswana 
and affiliated institutions animal care committee 
(Approval no: UB/IRB/1084). The animals were 
handled carefully to minimize the suffering. 
 
Plant collection and preparation of the plant extract  
The leaves of Ziziphus mucronata (Voucher no: 0010) 
were collected around Gaborone. The plant 
authentication was performed by Mr. M. Muzila of the 
University of Botswana Herbarium and the Herbalist 
Mr J Moshageng also helped in plant identification. 
They were washed with distilled water and sun dried. 
The dried plant leaves were crushed with a blender or 
laboratory grinder to obtain 500g of powder. The 
powder was soaked and extracted in 70% 
methanol/water for 24 hours. Using a rotary evaporator 
the methanol and water were evaporated resulting in a 
25% extract yield.  
 
Experimental design 
Twenty five adult male rats (aged 21 weeks) were 
divided into five groups of five rats each and treated as 
follows; 
Group 1 - normal control (NC) received distilled water 
Group 2 - dimethoate control (DC) received 6 
mg/kg.bw.day-1 dimethoate dissolved in distilled water 
Group 3 - Experimental Group (E1) received 
dimethoate (6 mg/kg.bw) + ZMLM (100 mg/kg.bw-1) 
Group 4 - Experimental Group (E2) received 
dimethoate (6 mg/kg.bw) + ZMLM (200 mg/kg.bw-1) 
Group 5 - Experimental Group (E3) received 
dimethoate (6 mg/kg.bw) + ZMLM (300 mg/kg.bw-1) 
Group 6 - Experimental Group (EO) received only 
ZMLM (300 mg/kg.bw-1)  
 
The experiment was run for 90 days and all the 
administration was done orally with the help of a 
rubber tube and syringe. At the end of the experiment, 
rats were killed after mild ether anaesthesia. Blood was 
collected in heparinised tubes and centrifuged at the 
rate of 6000 rotations per minute. Plasma samples were 
drawn after that and stored at -700C for further 
analysis. 
 
Determination of total phenol content 
The total phenol content (TPC) was determined using 
Folin-Ciocalteu reagent. One milliliter of extract or 
standard solutions (Gallic acid) (0-500 mg/l) was added 
to a mixture of 10 ml deionising water and 1.0 ml of 
Folin - Ciocalteu phenol reagent. After 5 minutes, 2.0 
ml of 20% sodium carbonate was added to the mixture. 
After 1 hour of incubation at room temperature in 
darkness the absorbance was measured at 750 nm. The 
TPC was calculated from the linear regression equation 
of the standard curve, from this equation, the 
concentration of gallic was determined for each extract 
and converted to mg of gallic acid equivalents/g of dry 
extract (mg GAE/g).7 
 
Biochemical measurements 
Thiobarbituric acid reactive substances (TBARS) 
Lipid peroxidation in plasma was estimated in terms of 
thiobarbituric acid reactive substance as described by 
Sushmakumari et al, (1989).8 with little modification. 
Original method describes the measurement of TBARS 
in tissue and it was adopted for plasma. Plasma or liver 
homogenate (0.1ml) was treated with 2 ml of TCA-
TBA-HCL (TBA 0.37%, 0.25N HCl and 15% TCA) 
reagent (1:1:1) and incubated in boiling water bath for 
10 minutes, the mixture was cooled and mixed with 
2ml of freshly prepared 1N NaOH and absorbance 
measured at 535 nm 
 
Serum glutamate oxaloacetate transaminase (SGOT) 
and serum glutamate oxaloacetate pyruvate 
transaminase (SGPT) 
Diagnostic kits for SGOT and SGPT were bought from 
Aggape Diagnostics, India and manufacture’s 
guidelines were strictly followed. The working reagent 
1000 µL and 100µL were mixed and incubated at 37oC 
for 1 minute at 37 oc. The change in absorbance per 20 
sec (OD/20 sec.) during 1 min 
SGOT activity (U/L) = (OD/min.) * 1745 
 
Reduced glutathione (GSH) 
Reduced glutathione was measured by the method 
described by Ellman et al, (1959). 9 Plasma was 
precipitated with metaphosphoric acid 0.25 ml of 
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plasma was mixed with 0.5ml of precipitating buffer 
(1.67g Metaphosphoric acid, 0.2g EDTA, 30g sodium 
chloride dissolved in 100 ml of double distilled water) 
and centrifuged. Supernatant was collected and mixed 
with 2.5ml of 0.3M phosphate buffer (pH 7.2). Colour 
was developed by adding 100µl of 0.01% 5, 5-dithiobis 
2-nitrobenzoic acid (DTNB) and read at 412 nm.  
 
Super oxide dismutase  
Super oxide dismutase was assayed by the method 
described by Tripathi et al, (2001).10 Plasma was 
treated with a mixture of chloroform and ethanol. The 
reaction mixture consisted of 150µl EDTA (0.5 mmol), 
600µl L-methionine (130 mmol) and 300µl NBT (750 
umol). The volume of reaction mixture was made up 
2.8µl with SOD buffer. Then 200µl of plasma was 
added except in the control. Finally 200µl of riboflavin 
was added to start the reaction. All the test tubes were 
placed under fluorescent lamp except the blank. 
Absorbance was recorded at 540nm after for 4 minutes. 
One unit of enzyme activity was calculated as the 
activity that was required to inhibit the reduction of 
NBT by 50%. 
 
Tocopherol (vitamin-e) 
Tocopherol was estimated using the method of 
Martinek (1964).11 The sample (0.5 ml), distilled water 
as blank (0.5ml) and standard solution (0.5ml) were 
taken in three centrifuge tubes. To all three tubes 0.5ml 
the xylene was added. The tubes were stoppered, 
mixed and centrifuged. The xylene layer (containing 
the precipitated tocopherol) was then carefully pipetted 
into clean tubes and mixed with 0.35 ml ∝-∝’ 
Dipyridyl reagent. The extinction of the test and 
standard against blank were read at 460nm. 
 
In turn, beginning with the blank tube, 0.33ml of ferric 
chloride solution was added to all the tubes. Optical 
density of the test and the standard against blank were 
read at 520nm after 1.5minutes. Amount of tocopherol 
present in mg/100 ml was calculated using the formula: 
Mg/100 ml = (Reading unknown at 520nm- Reading 
unknown at 460nm)* 0.29/ Reading of standard at 
520nm. 
 
Choline asterase activity 
Diagnostic kit for cholinesterase activity was bought 
from Aggape Diagnostics, India and manufacture’s 
guidelines were strictly followed. A working reagent of 
1000µL and 50 µL were mixed and incubated for 2 
minutes at 37oc. The absorbance was read after 1, 2 and 
3 minutes. The difference in Optical density divided by 
60 seconds during the three minutes was determined.  
 
Cholinesterase (U/L) = (OD/60 Sec) * 22653 
 
Lipid Profile 
High density Lipoproteins (HDL), Low-density 
lipoproteins (LDL), Cholesterol (CHOL), Total 
proteins (TP), and Triglycerides (Trig) were estimated 
according to Aggape diagnostic kit and the 
manufacturer’s guidelines were strictly followed.  
 
Histological studies 
The rat liver tissue intended for histological studies 
was removed and immediately fixed in 10% phosphate 
buffered formalin for at least 24 hours. The tissue was 
dehydrated in ethanol series (70%, 80%, 100%, and 
100%), cleared in xylene and embedded in paraffin. 5 
µm thick sections were taken using a rotary microtone 
and sections were affixed on clean glass slides by 
gentle heating. The slides were deparaffinised and 
stained with haematoxylins and eosin and they were 
mounted with a cover slip using DPX. The slides were 




Data were analyzed using Sigma-Stat 3.1.Statistical 
analyses were performed using one way analysis of 
variance (ANOVA) followed by Tukey’s test for com-
parison between groups. 
 
RESULTS 
Total phenol content of different types of leaf extracts 
of Z. mucronata (ZMLM) 
High phenol content was estimated in the ZMLM. The 
highest estimated phenol content was 271 mg GAE/g 
in 100% methanol extract, followed by 260, 120, 60, 
45 and 20 mgGAE/g in 70% methanol/water, 70% 
methanol/chloroform, 100% chloroform, 50% 
hexane/chloroform and 100% hexane respectively. 
(Table 1). 
 
Table 1 Total phenol content of the ZMLM. 
Leaf extract TPC 
(mgGAE/g) 
70% methanol 260 ± 3.6 
100% methanol 271 ± 2.4 
50% methanol/ chloroform 120 ± 1.6 
Chloroform  60 ± 0.4 
50% Hexane chloroform 45 ± 1.8 
Hexane  20 ± 0.2 
* Values are the average of three trials ± standard deviation 
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Daily administration of dimethoate resulted in elevated 
levels of TBARS in plasma of the DC (dimethoate 
control) group.  
A dose dependant reduction in the levels of plasma 
TBARS was associated with the ZMLM 
administration.  
 
The serum marker enzymes serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamate 
pyruvate transaminase (SGPT) and alkaline 
phosphatase (ALP) had increased significantly 
(p<0.05) in rats of group DC when compared with the 
levels in NC rats.  
A significant decline approaching normal activities 
were observed in the activities of SGOT (p<0.001), 
SGPT (p<0.001), and ALP (p<0.001) as a result of 
extract administration. The decrease on the plasma 
marker parameters was dependant on the dose of the 
extract, the higher the dose of the extract the more the 
decrease that occurred. No evident toxicity was 
observed on feeding ZMLM extract alone, there was no 
significant difference on the level of TBARS when 
compared with NC (Table 2). 
 
Table 2 Effects of ZMLM on plasma marker parameters of dimethoate treated rat. 
Groups TBARS(nmol/ml) SGOT(U/L) SGPT(U/L) ALP(U/L) 
NC 0.580 ± 0.013 42 ± 5.5 46 ± 2 69 ± 2.1 
DC 3.868 ± 0.002* 339 ± 8.2** 360 ± 5** 667 ± 3.0* 
E1 2.172 ± 0.006* 179 ± 9.1**/aa 168 ± 2**/aa 228 ± 4**/aa 
E2 1.200 ± 0.002*a 63 ± 2.7aa/* 59 ± 1** 90 ± 3** 
E3 0.982 ± 0.003*a 54 ± 1.2aa 41 ± 6** 70 ± 1** 
EO 0.576 ± 0.004a 43 ± 2.1aa 44 ± 3.8/aa 70 ± 3.5a 
Values are expressed as mean ±SEM n=5 for each treatment (p*<0.05, p**<0.001) compared with normal control and dimethoate 
control (pa<0.05, paa<0.001) respectively. E1 (100 mg/kg.bw extract + DM), E2 (200 mg/kg.bw + DM), E3 (300 mg/kg.bw ex-
tract + DM), EO (300 mg/kg.bw extract only). 
 
Effects on plasma enzymatic antioxidants (SOD, 
catalyse activities)  
Effects of ZMLM on plasma SOD and catalase are 
presented in (Table 3). The result showed that the 
activities of SOD (p<0.001) and catalase (p<0.05) 
enhanced significantly in DC rats as compared to the 
normal control (NC). Significant decrease in the 
activities of SOD (p<0.001) and catalase (p<0.001) 
were noticed in experimental groups in a dose 
dependent manner. The highest and significant 
reduction (p<0.05 for SOD and p<0.001 for catalase) 
was noticed in Group E3 when compared to DC. In this 
group, the level of activities is almost parallel to group 
NC and no significant difference was noticed after its 
comparison with NC. Group E1 showed similar results 
like DC and it differed significantly with NC.  
 
Table 3 Effects of ZMLM on plasma enzymatic 
antioxidants (SOD, catalase) in dimethoate treated rats.  
Groups SOD (U/mg) Catalase (Umg-1) 
NC 6.90 ± 0.13 503.6 ± 2.01 
DC 12.39 ± 0.21** 830.6 ± 3.71** 
E1 11.12 ± 0.04** 780.2 ± 1.31** 
E2 7.12 ± 0.06aa 657.9 ± 0.27aa 
E3 6.12 ± 0.06aa 607.2 ± 0.93aa 
*Values are expressed as mean ±SEM n=5 for each treatment 
(p*<0.005, p**<0.001) compared with normal control and 
dimethoate control (pa<0.005, paa<0.001).  
 
Effects on Plasma Non Enzymatic Antioxidants- 
Reduced Glutathione, Vitamin C and Vitamin E  
Effects of ZMLM on plasma non enzymatic anti-
oxidants against dimethoate administration are 
presented in (Table 4).  
 






NC 6.13 ± 0.99 6.28 ± 0.06 60.0 ±1.8 
DC 0.99 ± 0.00** 2.06 ± 0.00** 31.0 ± 2.1** 
E1 1.50 ± 0.09** 2.09 ± 0.11* 34.0 ± 1.2** 
E2 2.67 ± 0.07**/a 3.31 ± 0.03* 37.0 ± 1.3** 
E3 3.50 ± 0.04**/a 4.33 ± 0.00*/a 49.0 ± 0.23**/a 
*Values are expressed as mean ±SEM n=5 for each treatment (p*<0.05, p**<0.001) compared with normal control and dimetho-
ate control (pa<0.05, paa<0.001) respectively  
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The results showed that plasma levels of GSH, Vitamin 
C and Vitamin `E reduced significantly (p<0.001) in 
DC rats as compared to the levels in NC. When 
compared with NC, their levels were also reduced 
significantly (p<0.001) in experimental rats (E1-E3) in 
a dose dependant manner. Although levels of these 
anti-oxidants were low in experimental groups and they 
also differ significantly with levels in DC (p<0.05), 
ZMLM administration along with dimethoate had 
helped these animals to ameliorate the levels of these 
non enzymatic anti-oxidants. 
 
Effects on Plasma Lipid Profiles and Total Protein 
Results of ZMLM administration along with 
dimethoate on plasma lipid profile are presented in 
(Table 5). It shows that dimethoate administration had 
significantly lowered HDL levels (p<0.001) in DC 
groups. ZMLM administration had almost retained 
normal HDL levels in all experimental groups and they 
differ significantly (p<0.001) from DC. On the other 
hand dimethoate had significantly increased the levels 
of low density lipoprotein (LDL), cholesterol, total 
protein and triglyceride (p< 0.001) as compared to the 
levels in NC group.  
 
The LDL, Cholesterol, Total Protein and Triglyceride 
levels were found to decline significantly (p<0.05) in 
E3 as compared to DC and there is no significant 
difference was noted from NC. In E2, although a 
decline was noticed but still there existed a significant 
difference from NC. Similar response was noted for E1 
but the changes were less significant than E2.  
 
Effects on Acetyl-Cholinesterase Activity 
The cholinesterase activity declined significantly 
(p<0.05) in DC when compared to NC. There was a 
significant (p<0.05) increase in cholinesterase activity 
in all the experimental groups. In E1 although ZMLM 
administration increased the activities of cholinesterase 
a significant difference was noted from NC and not 
from DC. In E2 and E3, preventive effect was more 
pronounced with a significant difference from NC and 
DC. Difference from DC indicated an ability of the 
extract to retain normal Cholinesterase activity at 
higher dosages (Table 6).  
 
Table 5 Effects of ZMLM on plasma lipid and lipoprotein profiles in dimethoate treated rats. 
Groups HDL(mg/dL) LDL(mg/dL) CHOL(mg/dL) TP(gm/dL ) TG(gm/dL ) 
NC 56.09 ± 1.32 15.00 ± 2.23 10.20 ± 1.25 8.00 ± 1.03 61.00 ± 4.21 
DC 12.80  ± 1.14** 150.87±3.1** 124.40± 9.10** 2.00 ± 0.04** 230.00 ± 9.31** 
E1 42.31 ± 1.30aa 78.87 ± 5.83* 98.19 ± 9.34* 3.40 ± 0.01* 100.76 ± 8.27* 
E2 55.00 ± 2.44aa 40.23 ± 4.76* 37.16 ± 2.91*/aa 6.80 ± 0.11a 70.29 ±5.12a 
E3 61.00 ± 3.14aa 20.55 ± 5.19* 17.76 ± 3.17a 7.1 ± 0.33* 58.65 ± 7.68a 
*Values are expressed as mean ±SEM n=5 for each treatment (p*<0.05, p**<0.001) compared with normal control and dimetho-
ate control (pa<0.05, paa<0.001) respectively.  E1 (100 mg/kg.bw + DM), E2 (200 mg/ kg.bw extract + DM), E3 (300 mg/kg.bw + 
DM)  
 
Table 6 Effects of ZMLM on cholinesterase activity In 





NC 24200 ± 16   
DC 5647 ± 18* 
E1 8213 ± 26*     
E2 13280 ± 14*/a 
E3 17420 ± 13*/a 
Values are expressed as mean ±SEM n=5 for each 
treatment (p*<0.05, p**<0.001) compared with normal 
control and dimethoate control (pa<0.05, paa<0.001) 
respectively.  
 
Effects of Dimethoate on General Behaviour and 
Health 
In this study, no death was observed in any groups of 
rat. Rats in NC and E1-E3 groups did not show any 
sign of toxicity. Rats in DC showed reduced weight 
and were generally weak.  
 
Effect on Weight 
The weight was significantly (p<0.05) decreased in 
dimethoate-administered rats when compared to the 
normal control. A significant (p<0.005) increase in 
weight was observed in ZMLM extract administered 
rats when compared to dimethoate fed rats (Figure 1).  
 
Effects on Histology 
Table 7 summarises the histological findings of the 
liver. It revealed a preventive effect on the hepatocytes 
when compared to dimethoate control (NC). 
Dimethoate control group showed evident hepatic 
damage as shown by widening sinusoids, loss of 
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Figure 1 Weight changes on the rats fed dimethoate and graded doses of the whole leaf extract.  
NC-normal control, DC-dimethoate control, E1-100 mg/kg.bw, E2-200, E3-300 mg/kg.bw. 
*Values are expressed as mean ±SEM n=5 for each treatment (p*<0.05, p**<0.001) compared with normal control and 
dimethoate control (pa<0.05, paa<0.001) respectively 
 
The preventive effect was more evident with an 
increasing dosage of the ZMLM extract. The 
preventive effect was evident from reduced necrosis in 
ZMLM fed rats when compared to dimethoate fed rats, 
with a lot of necrosis and infiltration.  
 
Table 7 Effects of ZMLM on histology of liver in di-
methoate treated rats (Findings of light micrographs 
stained with eosin and haematoxylin at 400X) 
GROUP Histological Findings 
NC 
 
Normal and preserved hepatic cells with 
normal sinusoids 
DC Lots of fatty changes, widened sinusoids 
and reduced number of hepatocytes, ne-
crosis, and tissue degeneration of the lym-
phocytes 
E1 Most of the hepatic cells were well pre-
served with no marked necrosis  
E2 The hepatic cells were well preserved with 
no massive necrosis, when compared to 
normal control  
 
DISCUSSION   
Dimethoate contributes a significant risk to human as 
well as animal population which are exposed to it by 
any means. This study aimed to establish the protective 
role of Ziziphus mucronata leaf extract, which is a very 
common health drink in Botswana, in protecting liver 
against dimethoate toxicity. 6mg/kg.bw dosage was 
chosen in this study because it was found to induce 
toxicity by changing the antioxidant status in rats.3 
 
Medicinal plants are sources of diverse nutrients, many 
of which display antioxidant properties which are 
capable of protecting the body against both cellular 
oxidation reactions and pathogens.14 Dimethoate has 
been found to be metabolically activated by 
cytochrome P-450 mediated oxidative 
desulphurization, where it is converted into its oxygen 
analogue (omethoate).15 Omethoate has been indicated 
to be ten times toxic compared to dimethoate, it is this 
dimethoate oxygen analogue that has been associated 
to dimethoate induced oxidative stress.  
 
Dimethoate has been found to be carcinogenic in in 
vitro studies but no results were obtained from in vivo 
studies.16 Dimethoate mediated oxidative stress is 
responsible for the inhibition of cholinesterase 
activity.17 According to Shaheen et al, (2006),2 
dimethoate sub chronic exposure has lead to a change 
in the total antioxidant status in the liver, brain and 
kidney of rats. After dimethoate exposure there was an 
increase in lipid peroxidation, catalase, and glutathione 
reductase and superoxide dismutase activities.1  
 
Cholinesterase activity is a common biomarker to test 
Organophosphate (OP) toxicity. In this study a 
decrease in the activity of this enzyme was noticed in 
DC group which is in accordance with the previous 
reports.3 Dimethoate inhibits the activity of the enzyme 
cholinesterase that hydrolyse acytylcholine into acetyl 
and choline and hence the returning of cholinergic 
neurones to normal is prevented. Amelioration of 
enzyme activity was observed in E2 and E3 which 
were administered ZMLM along with dimethoate 
(Table 6) 
 
Dimethoate intoxication has been demonstrated to 
induce hepatic lipid peroxidation in rats.18 In the 
present study, administration of dimethoate for 90 days 
had raised the levels of TBARS in DC group hence 
confirming the previous reports on dimethoate toxicity.  
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Administration of ZMLM along with dimethoate had 
suppressed the lipid peroxidation significantly in E3. 
Results of DC and E1 do not differ significantly in 
terms of their plasma TBARS levels. This 
demonstrates that ZMLM fails to reduce the rate of 
lipid peroxidation induced by dimethoate when 
administered at low doses. (Table 2) 
 
High rate of lipid peroxidation in hepatic tissues causes 
severe damage to liver cells and leakage of 
transaminases like SGOT, SGPT and ALP into the 
circulation. SGOT and SGPT are transaminases 
localized in hepatic cells and they leak into the 
circulation after hepatic cell damage and thus show 
high levels in the blood.19 In the present study high 
levels of plasma SGOT, SGPT and ALP in DC 
indicates liver cell damage. Liver is central place for 
protein synthesis and damage to liver reduces the rate 
of protein synthesis and hence the levels of protein in 
the circulation.  
 
Low levels of total protein in DC could be due to liver 
damage by oxidative stress. Results of E2 and E3 
demonstrate low levels of SGOT, SGPT and ALP and 
high levels of total proteins. This translates to the 
protection rendered by ZMLM at the dose of 200 and 
300 mg/kg body weight in E2 and E3 respectively. 
Thus administration of ZMLM had significantly 
inhibited the oxidative stress generated by dimethoate 
metabolism and rendered protection in E2 and E3.  
 
Administration of only 300 mg/kg.bw ZMLM extract 
resulted in no signs of toxicity. This was evident from 
the level of TBARS that had no significant difference 
with NC. SGOT, SGPT and ALP activities also 
showed no significant differences when compared to 
NC (Table 2).  The results are consistent with previous 
findings by Taylor et al, (2003), 20 reporting no toxicity 
on Ziziphus mucrionata leaf, root and twig. 
 
Anti-oxidants are the defense system in the body to 
fight the toxicity associated with free radicals. Super 
oxide dismutase and catalase provide the first line of 
enzymatic anti-oxidant defense system against free 
radicals. The increased activity of superoxide 
dismutase and catalase reflects an activation of the 
compensatory mechanism through the effect of 
pesticide on progenitor cells, and its extent depends on 
the magnitude of oxidative stress and hence, on the 
dose of stressor. In the current study, there was an 
increase in the activities of catalase and SOD in DC 
group.  
 
The elevated SOD activity is due to an adaptive 
response to the generated free radicals.21 Under normal 
physiological conditions a delicate balance exists 
between the rate of formation of H2O2 via dismutation 
of O-2 by SOD activity and the rate of H2O2 removal by 
Catalase.1 The SOD activity was observed to rise 
significantly in DC compared to NC. The increase is 
because of an adaptive response due to dimethoate 
generated free radicals. A decrease in the SOD and 
catalase activities was observed in E2 and E3 where 
dimethoate was administered along with ZMLM. It 
appears that ZMLM takes over the work of scavenging 
free radicals and hence the normal levels of both 
enzymatic anti-oxidants were maintained. This is 
confirmed by E2 and E3 which show a significant 
difference with DC and with no significant differences 
with NC (Table 3). 
 
Glutathione is important non enzymatic anti-oxidant in 
neutralizing the reactive intermediates and radical 
species generated during oxidative stress.22 The 
depletion of GSH may be a result of it being used up in 
quenching Omethoate (an oxygen analogue generated 
from dimethoate biotransformation) radical. An oral 
feeding of ZMLM along with dimethoate seem to 
scavenge or interfere with free radical formation, thus 
it may have lead to normal production and hence the 
restoration of GSH levels (Table 4). 
 
Vitamin E is most important lipid soluble non 
enzymatic anti-oxidant which inhibits lipid 
peroxidation reaction and regenerates glutathione and 
vitamin C. It thus protects all the membranous 
structures. In our study, the decreased level of Vitamin 
C in plasma of DC could be explained by depletion of 
GSH because glutathione recycles this vitamin for 
further usage. ZMLM might have possibly played a 
role in scavenging the ROS, thus allowing the recovery 
of Vitamin E which was possibly used up in 
scavenging omethoate radical (Table 4).  
 
Apart from oxidative stress generated in DC, there was 
also a significant reduction in the level of plasma HDL 
along with increment in the levels of triglyceride, LDL 
and total cholesterol was noted in DC group. Free radi-
cals enhance the oxidation of light density lipoprotein 
(LDL) and oxidized LDL affects many biological pro-
cesses involved in atherogenesis. ZMLM has been suc-
cessful in elevating the levels of HDL and Vitamin E 
(Table 5). High HDL levels competes with LDL recep-
tors site on the smooth muscle cells of arterial wall  and 
inhibits the uptake of LDL and thus prevents the organ-
ism from the risk of atherogenesis.  
 
Vitamin E also inhibits the peroxidative damage and 
atherogenesis by protecting endothelial cells and inhib-
iting the oxidation of lipoproteins. High levels of Tri-
glyceride can accumulate in cardiac tissue because of 
its high uptake by cardiac muscle cells and lead to the 
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development of cardiomyopathy. Administration of 
ZMLM along with dimethoate successfully prevents 
these effects by lowering the levels of triglyceride in 
E2 and E3 rats. Extract administration significantly 
prevented weight loss in E2 and E3 when they are 
compared to DM (Table 5). 
 
To support the biochemical findings, histological 
studies of liver tissue were also performed. It revealed 
that lipid peroxidation induced by dimethoate has 
caused a significant change in liver histological 
features like widened sinusoids and reduced number of 
hepatocytes, necrosis and tissue degeneration. 
Supplementation of dimethoate administration with 
ZMLM in experimental groups has preserved the 
normal structure of liver with no massive necrosis. The 
structure of E2 and E3 were almost similar to the 
normal structure of liver in NC (Table 7). 
 
The results of this study clearly show that ZMLM 
renders protection against oxidative stress induced by 
dimethoate metabolism. There could be many reasons 
behind this, one being the richness of different leaf 
extracts in phenol content (Table 1). Phenols are well 
known to inhibit lipid peroxidation and reduce 
oxidative stress. Therefore there is a possibility that the 




Ziziphus mucronata methanol leaf extract possess a 
preventive effect against dimethoate induced oxidative 
stress in male albino Sprague dawley rats. 
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